Burlingame, California


Purpose:

The purpose of this study is to evaluate the accuracy of Somnarus diagnostic technology for diagnosis of sleep apnea in human subjects. This includes evaluation of Somnarus technology in Obstructive Sleep Apnea (OSA) and Central Sleep Apnea (CSA), including Cheyne - Stokes respiration (CSR).


Criteria:

Inclusion Criteria: - Able to understand and sign the informed consent - Able to comply with visits and follow ups included in this protocol - Ages 20-85 years Exclusion Criteria: - An unstable medical condition, acute or chronic, that in the opinion of the investigator puts the subject at health risks related this trial or interferes with the clinical trial and data collection. - Skin rash on the nose or on the maxillary area. - A history of skin allergy to medical tape, and hypoallergenic tapes. - A history of skin cancer on the nose or on the maxillary area. - A history of the base of skull fractures, facial fractures


NCT ID:

NCT02034175


Primary Contact:

Maria Merchant, PhD
Phone: 408-761-0884
Email: somnarus@gmail.com


Backup Contact:

N/A


Location Contact:

Burlingame, California
United States

Juliann Nealon, MD
Phone: 650-636-9396

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.